| PERIOD ENDING | 31-Dec-08 | 31-Oct-07 | | Total Revenue | 32,676 |
-
| | Cost of Revenue | 21,718 |
-
| | | Gross Profit | 10,958 |
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 3,417 | 30 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 7,542 | (30) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 407 |
-
| | Earnings Before Interest And Taxes | 7,949 | (30) | | Interest Expense | 314 |
-
| | Income Before Tax | 7,635 | (30) | | Income Tax Expense | 1,294 |
-
| | Minority Interest | (6) |
-
| | | | Net Income From Continuing Ops | 6,335 | (30) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 6,335 | (30) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $6,335 | ($30) |
|
0.26% Nasdaq 
0.46 (3.10%) 
Income Statement
